Hermione Price

Efficacy and safety of once-weekly semaglutide 1.0 mg vs once-daily liraglutide 1.2 mg as add-on to 1–3 oral antidiabetic drugs in subjects with type 2 diabetes (SUSTAIN 10)

Matthew Capehorn, Andrei‐Mircea Catarig, Julie Kjærulff Furberg et al. · Diabetes & Metabolism · 2019 · 376 citations

Diabetes Management, Diabetes, Pharmacology +7

Performance of the UK Prospective Diabetes Study Risk Engine and the Framingham Risk Equations in Estimating Cardiovascular Disease in the EPIC- Norfolk Cohort

Rebecca K. Simmons, Ruth L. Coleman, Hermione Price et al. · Diabetes Care · 2008 · 147 citations · Full text

Lack of confidence among trainee doctors in the management of diabetes: the Trainees Own Perception of Delivery of Care (TOPDOC) Diabetes Study

Jyothis T. George, David Warriner, David J McGrane et al. · QJM · 2011 · 80 citations · Full text

Use and effectiveness of a fixed‐ratio combination of insulin degludec/liraglutide (IDegLira) in a real‐world population with type 2 diabetes: Results from a European, multicentre, retrospective chart review study

Hermione Price, Matthias Blüher, Rudolf Prager et al. · Diabetes Obesity and Metabolism · 2017 · 67 citations · Full text

The use of liraglutide 3.0 mg daily in the management of overweight and obesity in people with schizophrenia, schizoaffective disorder and first episode psychosis: Results of a pilot randomized, double‐blind, placebo‐controlled trial

Clare Whicher, Hermione Price, Peter Phiri et al. · Diabetes Obesity and Metabolism · 2021 · 67 citations